Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 22 NOVEMBER 2016

Licensing Agreement For Multiple Pediatric-Focused Products Between Lupin And Monosol Rx

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide range of branded & generic formulations, biotechnology products...

IndiaIntellectual Property
Komal Tomar, Sr.
Komal Tomar, Sr.
Author LinkedIn connections

Reportedly, Lupin Pharmaceutical Inc.(LPI,US subsidiary of pharma major Lupin Limited) and MonoSol Rx, a specialty pharmaceutical company have entered into a strategic licensing agreement (OCT-2016) wherein Lupin would develop multiple pediatric products utilizing MonoSol Rx's patented PharmFilm® drug delivery technology.

Lupin Limited is an innovation led transnational pharmaceutical company which develops and offers a wide range of branded & generic formulations, biotechnology products, and active pharmaceutical ingredients (API) globally. Lupin is the 5th and the 7th largest1 generics pharmaceutical company by market capitalization and sales globally; the 3rd largest Indian pharmaceutical company2 by revenues; the 6th largest generic pharmaceutical company in Japan and the 4th largest in South Africa.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Copy, Right? ANI Media Pvt. Ltd. v. Open AI OpCo LLC

When an artificial intelligence system is trained on copyrighted news content, and later answers a user’s question using what it learned, has the law been broken? On 24th July 2026, the Delhi High Court answered that question, at least for now. In ANI Media Pvt. Ltd. v. Open AI OpCo LLC, Justice Amit Bansal declined to grant an interim injunction against OpenAI, holding, on a prima facie, interim stage view, that the company’s use of ANI’s news content to train its large language models (“LLMs”) falls within the fair dealing exception under Section 52(1)(a) of the Copyright Act, 1957
IndiaIntellectual Property
S.S. Rana & Co.
S.S. Rana & Co.
Article

Legal Metrology (Packaged Commodities) Amendment Rules, 2026: Enhancing Transparency And Consumer Protection In E-Commerce

The Legal Metrology (Packaged Commodities) Amendment Rules, 2026 introduce significant compliance obligations for e-commerce platforms, particularly regarding the disclosure of Country of Origin and other product information. This article analyses the key amendments, their implications for manufacturers, importers, and online marketplaces, and the broader objectives of strengthening consumer protection in the digital marketplace.
IndiaConsumer Protection
Khurana & Khurana, Advocates and IP Attorneys
Khurana & Khurana, Advocates and IP Attorneys
Article

Cross-Border Mould And Tooling IP : Protecting Manufacturing Assets In Outsourced Production

A comprehensive legal analysis of intellectual property ownership over moulds, tooling, CAD technical drawings, and product modifications in cross-border outsourced manufacturing. Covers supplier retention risks, unauthorised third-shift runs, ASEAN IP protection strategies for Indian OEMs, and a model supply-contract IP schedule.
IndiaIntellectual Property
Khurana & Khurana, Advocates and IP Attorneys
Khurana & Khurana, Advocates and IP Attorneys